Log In
BCIQ
Print this Print this
 

CyMVectin (Cytomegalovirus (CMV) vaccine)

  Manage Alerts
Collapse Summary General Information
Company Vical Inc.
DescriptionDNA vaccine encoding glycoprotein B and phosphoprotein 65 formulated with Vaxfectin lipid adjuvant
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent cytomegalovirus (CMV) infection in women of childbearing age
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today